
Transcatheter Interventions Online 2023 – Keynote & Debate

Transcatheter Interventions Online 2023 – Keynote & Debate is organized by Radcliffe Medical Education (RME).
Course Published On: 12/06/2023
Course Expiry Date: 12/06/2025
Topic:
Intervention
Overview:
The Keynote & Debate session, part of Transcatheter Interventions Online 2023 commences with an enlightening keynote lecture by Dr Roxana Mehran (Mount Sinai Hospital in New York, US) which highlights the importance of tailoring cardiac interventions to specific genders. Following the keynote, Dr Holger Thiele (Leipzig Heart Center in Leipzig, DE), presents a thought-provoking debate on the topic, 'Can We Walk Away From Dual Antiplatelet Therapy After PCI in CCS and ACS?'. This debate sets the base for a sparked discussion around the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with stable coronary syndrome and acute coronary syndrome. Transcatheter Interventions Online 2023 united renowned international experts to provide an immersive and dynamic platform, ensuring that the global interventional cardiology community stays informed about the most recent advancements in transcatheter treatment approaches. By integrating expert opinions, interactive discussions, presentations, and live cases from institutions across both sides of the Atlantic, TIO 2023 delivered exceptional educational content that supported the latest practices in diagnosis, treatment strategies, and patient care.
Learning Objectives:
The overall programme, "Transcatheter Interventions Online 2023", endeavours to best address the following learning objectives:
• Compare the utility of repair and replacement valve technology in mitral regurgitation
• Individualise valve choice for aortic regurgitation based on valve durability and patient features
• Recall the utility and limitations of specialty balloons
• Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
• Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
• Identify suitable patients for interatrial shunting
Additional details will be posted as soon as information is available.